Ursolic acid inhibits the initiation, progression of prostate cancer and prolongs the survival of TRAMP mice by modulating pro-inflammatory pathways.

Prostate cancer is one of the leading causes of cancer death among men worldwide. In this study, using transgenic adenocarcinoma of mouse prostate (TRAMP) mice, the effect of diet enriched with 1% w/w ursolic acid (UA) was investigated to evaluate the stage specific chemopreventive activity against...

Full description

Bibliographic Details
Main Authors: Muthu K Shanmugam, Tina H Ong, Alan Prem Kumar, Chang K Lun, Paul C Ho, Peter T H Wong, Kam M Hui, Gautam Sethi
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3299664?pdf=render
_version_ 1811270353348984832
author Muthu K Shanmugam
Tina H Ong
Alan Prem Kumar
Chang K Lun
Paul C Ho
Peter T H Wong
Kam M Hui
Gautam Sethi
author_facet Muthu K Shanmugam
Tina H Ong
Alan Prem Kumar
Chang K Lun
Paul C Ho
Peter T H Wong
Kam M Hui
Gautam Sethi
author_sort Muthu K Shanmugam
collection DOAJ
description Prostate cancer is one of the leading causes of cancer death among men worldwide. In this study, using transgenic adenocarcinoma of mouse prostate (TRAMP) mice, the effect of diet enriched with 1% w/w ursolic acid (UA) was investigated to evaluate the stage specific chemopreventive activity against prostate cancer. We found that TRAMP mice fed with UA diet for 8 weeks (weeks 4 to 12) delayed formation of prostate intraepithelial neoplasia (PIN). Similarly, mice fed with UA diet for 6 weeks (weeks 12 to 18) inhibited progression of PIN to adenocarcinoma as determined by hematoxylin and eosin staining. Finally, TRAMP mice fed with UA diet for 12 weeks (weeks 24 to 36) demonstrated markedly reduced tumor growth without any significant effects on total body weight and prolonged overall survival. With respect to the molecular mechanism, we found that UA down-regulated activation of various pro-inflammatory mediators including, NF-κB, STAT3, AKT and IKKα/β phosphorylation in the dorsolateral prostate (DLP) tissues that correlated with the reduction in serum levels of TNF-α and IL-6. In addition, UA significantly down-regulated the expression levels of cyclin D1 and COX-2 but up-regulated the levels of caspase-3 as revealed by immunohistochemical analysis of tumor tissue sections. Finally, UA was detected in serum samples obtained from various mice groups fed with enriched diet in nanogram quantity indicating that it is well absorbed in the GI tract. Overall, our findings provide strong evidence that UA can be an excellent agent for both the prevention and treatment of prostate cancer.
first_indexed 2024-04-12T21:59:33Z
format Article
id doaj.art-36dee9771ad24a3fb201600cfa9528bf
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-12T21:59:33Z
publishDate 2012-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-36dee9771ad24a3fb201600cfa9528bf2022-12-22T03:15:11ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-0173e3247610.1371/journal.pone.0032476Ursolic acid inhibits the initiation, progression of prostate cancer and prolongs the survival of TRAMP mice by modulating pro-inflammatory pathways.Muthu K ShanmugamTina H OngAlan Prem KumarChang K LunPaul C HoPeter T H WongKam M HuiGautam SethiProstate cancer is one of the leading causes of cancer death among men worldwide. In this study, using transgenic adenocarcinoma of mouse prostate (TRAMP) mice, the effect of diet enriched with 1% w/w ursolic acid (UA) was investigated to evaluate the stage specific chemopreventive activity against prostate cancer. We found that TRAMP mice fed with UA diet for 8 weeks (weeks 4 to 12) delayed formation of prostate intraepithelial neoplasia (PIN). Similarly, mice fed with UA diet for 6 weeks (weeks 12 to 18) inhibited progression of PIN to adenocarcinoma as determined by hematoxylin and eosin staining. Finally, TRAMP mice fed with UA diet for 12 weeks (weeks 24 to 36) demonstrated markedly reduced tumor growth without any significant effects on total body weight and prolonged overall survival. With respect to the molecular mechanism, we found that UA down-regulated activation of various pro-inflammatory mediators including, NF-κB, STAT3, AKT and IKKα/β phosphorylation in the dorsolateral prostate (DLP) tissues that correlated with the reduction in serum levels of TNF-α and IL-6. In addition, UA significantly down-regulated the expression levels of cyclin D1 and COX-2 but up-regulated the levels of caspase-3 as revealed by immunohistochemical analysis of tumor tissue sections. Finally, UA was detected in serum samples obtained from various mice groups fed with enriched diet in nanogram quantity indicating that it is well absorbed in the GI tract. Overall, our findings provide strong evidence that UA can be an excellent agent for both the prevention and treatment of prostate cancer.http://europepmc.org/articles/PMC3299664?pdf=render
spellingShingle Muthu K Shanmugam
Tina H Ong
Alan Prem Kumar
Chang K Lun
Paul C Ho
Peter T H Wong
Kam M Hui
Gautam Sethi
Ursolic acid inhibits the initiation, progression of prostate cancer and prolongs the survival of TRAMP mice by modulating pro-inflammatory pathways.
PLoS ONE
title Ursolic acid inhibits the initiation, progression of prostate cancer and prolongs the survival of TRAMP mice by modulating pro-inflammatory pathways.
title_full Ursolic acid inhibits the initiation, progression of prostate cancer and prolongs the survival of TRAMP mice by modulating pro-inflammatory pathways.
title_fullStr Ursolic acid inhibits the initiation, progression of prostate cancer and prolongs the survival of TRAMP mice by modulating pro-inflammatory pathways.
title_full_unstemmed Ursolic acid inhibits the initiation, progression of prostate cancer and prolongs the survival of TRAMP mice by modulating pro-inflammatory pathways.
title_short Ursolic acid inhibits the initiation, progression of prostate cancer and prolongs the survival of TRAMP mice by modulating pro-inflammatory pathways.
title_sort ursolic acid inhibits the initiation progression of prostate cancer and prolongs the survival of tramp mice by modulating pro inflammatory pathways
url http://europepmc.org/articles/PMC3299664?pdf=render
work_keys_str_mv AT muthukshanmugam ursolicacidinhibitstheinitiationprogressionofprostatecancerandprolongsthesurvivaloftrampmicebymodulatingproinflammatorypathways
AT tinahong ursolicacidinhibitstheinitiationprogressionofprostatecancerandprolongsthesurvivaloftrampmicebymodulatingproinflammatorypathways
AT alanpremkumar ursolicacidinhibitstheinitiationprogressionofprostatecancerandprolongsthesurvivaloftrampmicebymodulatingproinflammatorypathways
AT changklun ursolicacidinhibitstheinitiationprogressionofprostatecancerandprolongsthesurvivaloftrampmicebymodulatingproinflammatorypathways
AT paulcho ursolicacidinhibitstheinitiationprogressionofprostatecancerandprolongsthesurvivaloftrampmicebymodulatingproinflammatorypathways
AT peterthwong ursolicacidinhibitstheinitiationprogressionofprostatecancerandprolongsthesurvivaloftrampmicebymodulatingproinflammatorypathways
AT kammhui ursolicacidinhibitstheinitiationprogressionofprostatecancerandprolongsthesurvivaloftrampmicebymodulatingproinflammatorypathways
AT gautamsethi ursolicacidinhibitstheinitiationprogressionofprostatecancerandprolongsthesurvivaloftrampmicebymodulatingproinflammatorypathways